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From the 
President 
"Skill in the art of 
communication is crucial to a leader's 
success. He can accomplish nothing unless 
he can communicate effectively." 
- Norman Allen 
Colleagues: 
At the General Medical Staff meeting on 
December 13, I announced that beginning 
January 1, 2000 all announcements from the 
medical staff office will be sent to members 
of the combined medical staff via e-mail. We 
will also send the same announcements to 
members of the staff via the usual printed 
format. Our plan will be to continue the dual 
proces$ of delivering e-mail and printed 
announcements for the next year. On 
January 1, 2001, all medical staff 
announcements will only be sent via e-mail. 
I would encourage all members of the staff 
to begin to read their e-mail regularly. If you 
can't bring yourselves to do this, please 
appoint a member of your staff to serve as 
your e-mail surrogate to read and print out 
your e-mail for you. We are entering the 
new millennium. This is the age of 
information. The hospital has just converted 
to an upgraded and more powerful network 
with new network software and "single sign-
on" capability. I'm sure that most of you are 
already using the Internet from either your 
homes or offices. We will be receiving more 
and more of our information electronically. It 
is time for the medical staff of the Lehigh 
Valley Hospital/Muhlenberg Hospital Center 
to enter the "electronic age." This is a 
simple first step. I would encourage you to 
try the process and see if you think e-mail 
will help in your daily practice and perhaps 
even improve clinical communication 
between members of the medical staff. 
(Continued on Page 2) 
Medical Staff Progress Notes January, 2000 * Volume 12, Number 1 Page2 
(Continued from Page 1) 
We all now have the new "GUI" (Graphical User Interface) e-
mail system. This allows us to attach documents to e-mail 
messages. We can send information to our colleagues directly 
about patients and attach office notes typed on any word 
processing program. I believe that this will be an expeditious 
way to improve the flow of clinical information between 
members of the medical staff. 
Also at the General Medical Staff meeting, Dr. Robert 
Laskowski made an excellent presentation about the 
importance of the activities of the Care Management Council 
directed to influencing our practice in the care of hospitalized 
patients. Bob pointed out how the monies generated through 
"operations improvement" provide the capital to invest in new 
equipment and programs for the care of our patients in the 
future. Without these funds we will be forced to "live with what 
we have." 
As an example, Bob pointed out the commitment that the 
members of the vascular surgery division have made to 
operations improvement. They are very anxious to have the 
hospital purchase the equipment, which they need for the 
development of the capability to perform endovascular surgical 
procedures. The funds for this equipment will become 
available through their commitment and efforts to shorten 
length-of-stay for many of their patients with complicated lower 
extremity vascular disease. Without similar commitments by 
many members of the medical staff, funds to make capital 
investments in new equipment and programs will simply not be 
available. 
Bob and John Jaffe, as co-chairs of the Care Management 
Council, have stressed the importance of "length-of-stay" 
reductions for our hospitalized patients as the "engine" which 
will generate the funds for capital investment. I know that 
many of you are growing weary of my preaching about "length-
of-stay." Perhaps we should be thinking more about what we 
are doing for our patients in the hospital and whether the 
patients' conditions justify a continued stay in a hospital 
environment. "lnterQual" criteria take into account the severity 
of the patient's condition, and the need for inpatient service. 
Dr. Keith Doram, our chief of General Internal Medicine, has 
pointed out the utility of these guidelines in deciding whether 
patients need to remain in the hospital. Could what we are 
doing for our patients today in the hospital be done just as 
well, at less cost, and with more comfort for the patients in 
some setting other than the hospital? 
Many of my surgical colleagues schedule their patients for 
elective surgical procedures and know approximately how long 
the patient will need to remain in the hospital for that 
procedure. Most of our "medical" patients and many surgical 
patients are not scheduled electively, but are admitted with an 
acute medical or surgical problem. I would encourage the 
attending physicians to begin to consider the expected "length-
of-stay" for all patients upon their admission. 
~ How long do I think this patient will need to be hospitalized 
for this problem? 
~ What discharge plans do I need to consider on admission 
so that the patient and family will be ready for the 
patient's discharge on the expected date? 
Patients, families, and caregivers should be educated as to 
this expected date of discharge and what they will need to do 
to prepare for the discharge. The hospital's Clinical Case 
Managers can obviously help to see that the appropriate plans 
for hospital discharge and post hospital care are formulated. 
In this age of radical cost pressures on the hospital, we do, 
unfortunately, need to pay attention to the "length-of-stay" of 
our patients. As much as physicians hate to think that our 
patients' care is being regulated and "rationed" by the 
economics of the present health care reimbursement system, 
we do need to pay attention to these issues. The survival of 
the hospital and its ability to provide capital resources for new 
equipment and programs depends on the availability of funds 
which can only be generated by us working with the hospital to 
develop more efficient ways to care for our patients. 
Most of us have already heard something about the Institute of 
Medicine Report of November 29, 1999. Issued by the Quality 
of Health Care in America Committee, this report -- To Err is 
Human: Building a Safer Health System -- is available on 
the Internet at http://www4.nationalacademies.org/news.nsf. 
Although it may be possible to direct some criticism at the 
methods employed to develop this report, the issues raised by 
the report deserve our attention and thoughtful consideration. 
Is our health care system unsafe? Is the current health care 
system in which we work fraught with errors that are frequently 
harmful or lethal to the patients whose lives we are committed 
to improving? 
We need to consider the things we do each day in the hospital, 
which have the potential to result in errors and harm to our 
patients. One of these is the very common problem, which is 
shared by many physicians (including myselij, of handwriting 
which is difficult to read or even illegible. Notes and orders 
that we write in patients' charts which are difficult for the 
nursing and secretarial staffs to read create the potential for 
untoward events occurring to our patients. The nursing and 
secretarial staffs, in trying to decipher these illegible orders, 
waste considerable time. This time could be more productively 
devoted to patient care. Incorrect dosages of medication or 
even the administration of unintended medications to our 
patients can occur as a result of our haste in writing orders, 
which are confusing or illegible. 
(Continued on Page 3) 
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One suggestion has been for physicians to print their names 
and pager number after their signature when writing orders or 
progress notes. If the nursing staff has difficulty interpreting an 
order, they can then easily identify the physician who wrote the 
order so that the confusion may be quickly clarified. There 
was a discussion of this suggestion at the December Medical 
Executive Committee meeting. I believe that for those of us 
who have trouble writing clearly the suggestion to follow written 
orders with a printed name and pager number makes sense 
and is a simple way to try to reduce errors. 
I point out that The Bylaws of the Common Medical Staff of 
the Lehigh Valley Hospital and Muhlenberg Hospital 
Center have specific language dealing with the legibility of the 
inpatient medical record: 
"All orders and progress notes written on the chart 
shall be dated. Timed documentation is encouraged. 
All orders must be written clearly, legibly and 
completely. Orders which are illegible or 
improperly written will not be carried out until 
rewritten or understood by the nurse. Any 
practitioner with non-legible handwriting will be 
required to print or stamp his or her full name 
under his or her signature."1 (My emphasis). 
I also believe that the use of a computerized physician order 
entry system would further help to reduce errors in the 
hospital. Some of us have seen such a system in operation in 
Boston. The experience there has been that a significant 
reduction has occurred in the number of errors related to the 
dispensing and delivery of medications to hospitalized patients. 
I believe that the hospital administration and interested 
physicians need to study the possibility of implementing such a 
system. I'm sure that in the future all of us will be using some 
type of computerized order entry system in our practice in the 
hospital. 
Sit, Answer and Touch! 
Remember, when you are making hospital rounds to sit at your 
patient's bedside, ask for their questions, answer their 
questions, and make physical contact with the patient. 
Members of the medical and nursing staffs have informed me 
that many of the inpatient nursing units at the LVH do not have 
Physician's Desk References available for use. Many of 
1
The Bylaws of the Common Medical Staff of the Lehigh 
Valley Hospital and Muhlenberg Hospital Center. 
September 8, 1999. Part II, MEDICAL STAFF RULES AND 
REGULATIONS, E. Records, #11. Page 84. 
these volumes have disappeared over time. I would 
encourage members of the medical staff who have used 1999 
editions of the PDR to bring them to the Medical Staff Office so 
that they can be distributed to the nursing units which currently 
do not have access to this useful volume. I'd remind the 
physicians on the staff that we all have Micromedex available 
at all of the computer workstations for reference regarding 
medications. 
E-MAIL 
Once again, I'd like to encourage all members of the Medical 
Staff to read their e-mail regularly or to designate a staff 
member to be your appointed a "surrogate", who can read and 
print out your e-mail messages for you on a daily basis. If you 
or your staff need help in assigning a "surrogate," please call 
Information Services at (61 0) 402-8303, then press "1." 
I hope that the above "communication" has provided some 
thought provoking information for the Medical Staff to ponder 
over the next month. Finally, I'd like to wish all of my 
colleagues on the Medical Staff a very safe and Happy New 
Year. 
David M. Caccese, MD 
President, Medical Staff 
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Influenza A has Arrived! 
Please take note of the following points for assistance in the 
management of suspected and confirmed Influenza A patients 
in the hospital environment. 
);> If you Strongly Suspect or Know a patient has Influenza 
infection, place the patient in Droplet Isolation (private 
room, mask when within 3 feet of patient). 
);> Suspected cases can be confirmed by viral culture or 
made clinically (high fever, severe myalgia, multiple 
cases, short (three day) incubation). Health Network 
Laboratories offer a Rapid Influenza A Screen test. If the 
rapid screen is negative, cultures will automatically be set 
up for an Influenza AlB Culture Screen. Viral culture kits 
are available through Health Network Laboratories by 
calling (610) 402-8170. A doctor's order for Influenza 
Culture should suffice. 
);> Rimantadine (Fiumadine®) at 100 mg twice a day is 
helpful for prevention or therapy for Influenza Type A. 
Modify dosage to 100 mg once a day for renal 
insufficiency and age 65 years and above. 
);> Infection Control will notify the physicians of roommates 
of patients identified with influenza to alert them to the 
potential exposure. In these instances, it is recommended 
the physician inquire about vaccination history and then 
watch for flu - like symptoms in unvaccinated patients. 
);> Patients vaccinated for influenza post exposure should be 
continued on rimantadine for 14 days allowing for the 
vaccine to take effect. 
);> If Influenza Type 8 becomes clinically evident, there are 
two new medications for Type 8 -- oseltamivir (Tamiflu®) 
and zanamivir (Relenza®) -- which you may want to 
investigate. 
);> Although the optimal time for influenza vaccination is 
October through mid-November, health-care providers 
should continue to offer influenza vaccine up to and even 
after influenza activity has been detected in the 
community, particularly to those persons at high risk for 
influenza-related complications. 
Individuals at high risk for complications from influenza should 
be placed on a yearly vaccination schedule for influenza by 
their health care provider. In addition, all health care providers 
should be vaccinated to reduce the risk of transmission to 
patients. Any additional questions can be directed to the 
Infection Control Department at (610) 402-0680. 
COPD and CAP Guidelines 
Clinical pathways/guidelines have been developed for patients 
admitted to Lehigh Valley Hospital at Cedar Crest & 1-78 with 
COPD or with Community Acquired Pneumonia (CAP). Input 
from representatives of several key areas within the hospital 
was obtained, including Family Practice, General Internal 
Medicine, Pulmonary Medicine, Infectious Diseases, Nursing, 
Respiratory Therapy, Pharmacy, and Care Management. It is 
hoped that the use of these guidelines will result in improved 
clinical outcomes and more cost efficient care. In order to 
facilitate the use of these guidelines and to promote physician 
awareness and utilization, pre-printed admission orders have 
been generated for both of these diagnoses. These orders are 
meant to facilitate the admission process for physicians 
admitting patients with COPD or CAP. Of course, addition to 
or subtraction from these orders, at the discretion of admitting 
physicians, are encouraged to maximize any individual 
patient's care. Pre-printed admission order sheets and copies 
of the pathways are now available on all of the nursing units 
and in the Emergency Department at Cedar Crest & 1-78. 
Data will be collected on certain key outcomes, including 
length of stay, to determine if these guidelines and pre-printed 
orders make a difference in managing patients with COPD or 
CAP. As this data becomes available, the results will be 
disseminated to the medical staff and other clinical staffs. 
Providing our patients with the best care possible while 
attempting to be as cost efficient as possible is a top priority. It 
is hoped that these pathways will help to achieve that goal. 
Please utilize them for your patients with COPD and CAP. 
If you have any questions or concerns regarding this issue, 
please page Jay H. Kaufman, MD, Chief, Division of 
Pulmonary, on beeper (610) 920-7221 or Marlene Ritter, Care 
Management Department, on beeper (610) 830-7081. 
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News from the Department of Care and 
Resource Management 
Currently, the Department of Care and Resource Management 
performs the following functions: 
).- Case Management 
).- Quality/Performance Improvement 
).- Clinical Information Analysis 
Paula Stillman, MD, Senior Medical Director, Care and 
Resource Management, is pleased to announce the following 
changes which more accurately reflect the roles within the 
Care and Resource Management Department. 
Case Managers, formerly known as Clinical Resource 
Managers, have the following roles and responsibilities: 
).- Meet with the patient and/or family on admission, or prior 
to admission, to assess needs for hospital care. 
).- Work with the patient/family and health care team to 
formulate post-hospital care plans including transfers to 
SNF, Rehab, coordination of home health, and arranging 
medical equipment. 
).- Communicate with insurance companies to obtain 
authorization for inpatient stay as well as follow-up 
services. 
).- Facilitate efficient and timely care of the patient. Insure 
appropriateness of setting for service. 
To best meet the needs of our patients, case managers are 
assigned to each inpatient care unit, as well as the Emergency 
Department. They are available Monday through Friday from 8 
a.m. to 4:30 p.m., and there is a case manager on call after 
hours. To provide services on weekends, three case 
managers are in-house at Lehigh Valley Hospital. 
Susan Lawrence, Administrator of Quality and Case 
Management, carries network-wide responsibilities for 
Performance Improvement and Case Management. Maureen 
Sawyer is the Director of Case Management at Muhlenberg 
Hospital Center and the Transitional Skilled Unit. 
Clinical Information Analysts, formerly known as Clinical 
Process Development Coordinators, have the following roles 
and responsibilities: 
).- Retrieve and analyze data from a variety of databases. 
).- Develop reports to allow for ongoing measurement of care 
management initiatives. 
).- Facilitate new care management and operation 
improvement strategies. 
).- Track outcomes associated with clinical process change. 
Beth Karoly is the Senior Clinical Information Analyst. Her 
associates include Jo Ann Gruber, Marlene Ritter and Marsha 
Faden. 
The goal of the Department of Care and Resource 
Management is to provide one-stop shopping for your clinical 
data needs. If you require clinical information to help you 
provide better care for your patients or to answer a clinical 
question, please call the Department of Care and Resource 
Management at (610) 402-1770 or (610) 402-1760. 
Ultrasound Preliminary Reports at 
Muhlenberg Hospital Center 
The Ultrasound Department at Muhlenberg Hospital Center is 
implementing a new way to report preliminary ultrasound 
findings to the physicians on all inpatients and Emergency 
Department patients. A preliminary interpretation form will be 
inserted in the radiology section of the patient chart for both 
positive and negative findings immediately following the exam. 
With the availability of this information, the radiologists will no 
longer need to call the ordering physician unless a phone call 
is specifically requested at the time the order is written. 
This change is being made to improve the efficiency of relaying 
findings to the nursing staff and physicians. It has already 
proven successful at both Cedar Crest & 1-78 and 171h & Chew. 
If you have any questions regarding this issue, please contact 
Janice Hickey, ROMS, lead sonographer, at (610) 861-2276. 
Clinical Trial for Depression 
As part of a national study, Lehigh Valley Hospital is currently 
enrolling adults with symptoms of depression in a clinical trial 
for an investigational drug. Enrollees receive a free 
depression screening and medical evaluation. After the 
screening and evaluation, if qualified, the participant will 
receive the drug and study-related medical attention for one 
year. There is no placebo. Participants must be medically 
stable otherwise. Laurence P. Karper, MD, Medical Director, 
Behavioral Health Emergency Services, is the principle 
investigator for the study. For more information, call 
(610) 402 -CARE. 
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Good Shepherd Specialty Hospital-Allentown: ~ Linda Dean, Administrative Consultant, at (610) 402-8963 
Opening Scheduled for January 17, 2000 or pager (610) 830-3110 
Is the project on target with its deadlines? 
Yes, six of the beds of the Good Shepherd Specialty Hospital-
Allentown (GSSH) will be ready to receive patients on 6C by 
January 17, 2000. In mid-June, the remaining 26 beds will be 
available. 
How do I get privileges to practice in the Good Shepherd 
Specialty Hospital-Allentown? 
All Lehigh Valley Hospital physicians are welcome to join the 
medical staff in order to provide continuity of care from the 
hospital into the GSSH. All you need to do is stop by the 
GSSH Administrative Office on the first floor of the hospital and 
write your name on the application, sign a consent to access 
your credentials file in the Lehigh Valley Hospital Medical Staff 
Services Office, and complete the delineation of privileges 
form. 
How is the programming in the Good Shepherd Specialty 
Hospital-Allentown (Long Term Acute Care Hospitai-
L TACH) different from traditional acute care? 
Each patient will receive care from a program specific 
interdisciplinary team of nursing, therapy and physician 
specialists. Under the direction of the three program medical 
directors (pulmonary, medically complex, and rehabilitation), 
additional care providers will be assigned to each patient 
depending on need. These care providers include respiratory 
therapists, care managers, physical, occupational, speech and 
recreation therapists, and psychologists. Pastoral and 
education services will be available to all patients and their 
families. The team will meet formally each week to discuss 
each patient's progress. 
If I choose to attend my patients, what are my 
responsibilities? 
If you choose to attend your own patients, daily medical 
management is expected. In addition, you are required to 
attend a weekly team conference to discuss your patient(s) 
status, goals and plans. Typically, each patient is discussed 
for 5-1 0 minutes. 
Who is available to answer questions about the Good 
Shepherd Specialty Hospital-Allentown? 
The following individuals can answer your questions: 
~ Stephen C. Matchett, MD, GSSH Medical Director, at 
(610) 439-8856 or pager (610) 920-7225 
~ Jane Dorval, MD, GSSH Medical Staff President, at (61 0) 
776-3340 or pager (61 0) 830-2793 
~ Joseph Pitingolo, GSSH Administrator, at (61 0) 402-8559 
or pager (610) 830-4389 
~ Nancy Hardick, Medical Staff Affairs, at (610) 402-8962 
Recruiting Physicians to Your Practice 
The Physician Recruiting Service of Lehigh Valley Health 
Network is now available to private practices that are primarily 
affiliated with Lehigh Valley Hospital or Muhlenberg Hospital 
Center. With over 10 years of experience in recruiting 
physicians to Lehigh Valley Hospital, the professional team of 
recruiters is well prepared to assist private practices in their 
recruiting needs. In fact, this group has been responsible for 
recruiting over 115 members of the current medical staff of 
Lehigh Valley Hospital. Physicians in a wide spectrum of 
specialties and subspecialties have been recruited, from family 
physicians and the Chairperson, Department of Pediatrics, to 
neuropathologists and pulmonary/critical care subspecialists. 
In addition to managing physician searches for Lehigh Valley 
Hospital, the team has conducted searches for a number of 
private practices affiliated with Lehigh Valley Health Network. 
Physicians have been successfully recruited for the following 
practices: 
• Allentown Anesthesia Associates Inc. 
• Allentown Associates in Psychiatry and Psychology 
• Allentown Infectious Diseases Service 
• Health Network Laboratories 
• Muhlenberg Primary Care, PC 
• Pulmonary Associates 
• Urologic Associates of Allentown Inc. 
• Valley Gastroenterologists 
The Physician Recruiting Service also assists other 
PennCARE hospitals in their searches and has, for example, 
recruited 1 0 physicians for Grand View Hospital over the past 
three years. 
Services provided by Physician Recruiting of Lehigh Valley 
Health Network include finding qualified candidates, arranging 
their on-site visits, and working closely with spouses and 
families to promote the Lehigh Valley area. These services 
are provided at a fraction of the cost typically charged by 
outside search firms. 
This is an excellent opportunity to use a proven service at a 
reasonable cost. Physicians who are considering adding to 
their practices should contact Carol G. Voorhees, Director of 
Physician Recruiting, at (610) 402-7008. One of the recruiters 
will come to your office to consult with you on your recruiting 
plans. 
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FIRST FLOOR 
Diagnostic Care Center 
Nuclear Medicine, Pulmonary, Sleep Study, blood draw, Heart 
Station, Neurophysiology (EEG), and Pre-Admission Testing. 
SECOND FLOOR 
ExpressER 
Treatment for minor bumps and bruises, simple cuts and 
broken bones ... with LVHHN's full service Emergency 
Department right around the comer if needed. 
Bum Center 
A large family room and overnight accommodations designed 
for families who travel from outside the Lehigh Valley. 
Intensive Care Unit 
This 28-bed unit combines medical, surgical and trauma-neuro 
intensive care focusing on care of the patient as well as 
convenience of the family. 
THIRD FLOOR 
Labor & Delivery 
Twelve birthing suites provide the "ultimate birthing 
experience" in a home-like setting with massage tub, whirlpool 
and cozy living room settings; 10 suites for mothers with high-
risk pregnancies and access to three perinatologists. 
FOURTH FLOOR 
Mother & Baby Unit 
After the new baby arrives, mothers and exhausted dads can 
relax in one of 27 private family rooms with sleeping chairs, 
seated showers and special bassinets. 
Neonatal Intensive Care Unit 
The most experienced NICU in the region. 
Pediatric Intensive Care Unit 
The Lehigh Valley's first pediatric intensive care unit in 
partnership with The Children's Hospital of Philadelphia 
(CHOP). 
Congratulations! 
Trent P. Conelias, DDS, Division of Oral and Maxillofacial 
Surgery, has satisfied the requirements of the American Board 
of Oral and Maxillofacial Surgery, and has become certified as 
a Diplomate in the specialty of Oral and Maxillofacial Surgery. 
Samuel W. Criswell, Sr., MD, Department of Family Practice, 
was recently notified that he successfully completed the 
Recertification Examination and has become recertified as a 
Diplomate of the American Board of Family Practice. 
Thomas C. Dotson, MD, Division of General Internal 
Medicine, was recently notified by the American Board of 
Internal Medicine that he passed the August 1999 Certification 
Examination and is now certified as a Diplomate in Internal 
Medicine. 
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Papers, Publications and Presentations 
Herbert L. Hyman, MD, Division of Gastroenterology, spoke 
on Chronic Fatigue Syndrome at Fellsmere Medical Center in 
Fellsmere, Fla., in early November. 
lndru T. Khubchandani, MD, Division of Colon and Rectal 
Surgery, was the invited speaker at the XVI Latin American 
Congress of Coloproctology held in Santiago, Chile, from 
October 28 to 31. At the meeting, Dr. Khubchandani gave the 
Bacon Oration titled "Colectomy and lleorectal Anastomosis in 
Ulcerative Colitis." He was also a member of the panel 
discussion on "Controversies in the Surgical Treatment of 
Hemorrhoids" and showed two videos of surgical techniques of 
"Transanal Repair of Rectocele" and "Resection for 
Colovesical Fistula with Hand Sewn Anastomosis." 
In addition, Dr. Khubchandani attended the meeting of the 
Northeastern Society of Colon and Rectal Surgeons held in 
Palm Beach, Fla., from November 7 to 10. Dr. Khubchandani 
spoke on "Refinements in the Technique of Closed 
Hemorrhoidectomy" and moderated a panel titled "How do you 
do it?" 
The Northeastern Society of Colon and Rectal Surgeons 
meets annually and is a composite conference of the 
Pennsylvania Society of Colon and Rectal Surgeons, the New 
York Society of Colon and Rectal Surgeons, the New Jersey 
Society of Colon and Rectal Surgeons, and the New England 
Society of Colon and Rectal Surgeons. 
Alan B. Leahey, MD, Associate Chief, Division of 
Ophthalmology, recently authored a book chapter--
"Molluscum Contagiosum" which appears in Current Ocular 
Therapy, edited by Fraunfelder and Roy. 
Upcoming Seminars, Conferences and 
Meetings 
Medical Grand Rounds 
Medical Grand Rounds are held every Tuesday beginning at 
noon in the auditorium of Lehigh Valley Hospital, Cedar Crest 
& 1-78, and via videoconference in the First Floor Conference 
Room of Muhlenberg Hospital Center. Beginning in January, 
Medical Grand Rounds will also be videoconferenced to 17tn & 
Chew every Tuesday at noon. This interactive Medical Grand 
Rounds will be televised in the VTC Room, formerly the 
Medical Staff Lounge, adjacent to the cafeteria on the first 
floor. 
Topics to be discussed in January will include: 
~ January 4 - "What Difference Does Difference Make: 
Culture, Religion and Ethnicity in the Medical Setting" 
~ January 11 - To Be Announced 
~ January 18 - Occupational Lung Diseases 
~ January 25- Trauma and the Geriatric Patient 
For more information, please contact Diane Biernacki in the 
Department of Medicine at (610) 402-5200. 
Department of Pediatrics 
The Department of Pediatrics conferences are held on Fridays 
beginning at noon in the auditorium of Lehigh Valley Hospital, 
171h & Chew. 
The topics for January will be: 
~ January 14 - Adolescent Medicine 
~ January 28 - Dermatologic Problems in Infants 
For more information, please contact Kelli Ripperger in the 
Department of Pediatrics at (610) 402-2540. 
Trends in the Treatment of Peripheral 
Vascular Disease 
"Trends in the Treatment of Peripheral Vascular Disease," a 
symposium sponsored by the Circulatory Center, will be held on 
Saturday, February 5, 2000, from 7:30a.m. to 12:15 p.m., in the 
Auditorium of Lehigh Valley Hospital at Cedar Crest & 1-78. 
Cardiologists, cardiothoracic surgeons, radiologists, and 
vascular surgeons will benefit from this program. 
Controversies in peripheral angioplasty from the perspectives 
of a cardiologist, vascular surgeon, and interventional 
radiologist will be discussed. State-of-the-art and national 
trends will be presented by David Katz, MD, JD, Senior 
Director of Medical Affairs with the Advisory Board Company. 
For additional information, please contact Sherry Haas in Care 
Management Systems at (610) 402-1770. 




Suzette V. Barreto, MD 
Eric Schoeppner, MD, PC 
1725 Northampton Street 
Easton, PA 18042-3133 
(610) 253-7211 * Fax: (610) 252-8685 
Department of Medicine 
Division of General Internal Medicine 
Site of Privileges - LVH & MHC 
Provisional Active 
Joseph C. Bognet, DO 
Bognet Medical Associates, PC 
451 Chew Street, Suite 304 
Allentown, PA 18102-3423 
(610) 821-2820 * Fax: (610) 821-9577 
Department of Family Practice 
Site of Privileges - LVH & MHC 
Provisional Active 
Dennis B. Cornfield, MD 
Health Network Laboratories 
Lehigh Valley Hospital 
17th & Chew, P.O. Box 7017 
Department of Pathology 
Allentown, PA 18105-7017 
(610) 402-2237 * Fax: (610) 402-9692 
Department of Pathology 
Division of Hematopathology 
Site of Privileges - LVH & MHC 
Provisional Active 
Albert N. Dandegian, MD 
Medical Imaging of LV, PC 
Muhlenberg Hospital Center 
2545 Schoenersville Road 
Bethlehem, PA 18017-7384 
(610) 861-2271 * Fax: (610) 867-7376 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Site of Privileges - LVH & MHC 
Provisional Active 
Becky M. Fox, DMD 
Elizabethtown Dental Associates 
1 00 Continental Drive 
Elizabethtown, PA 17022 
(717) 367-1336 * Fax: (717) 367-7904 
Department of Dentistry 
Division of General Dentistry 
Site of Privileges - LVH & MHC 
Provisional Active 
Barry E. Herman, MD 
Twin Rivers Gastroenterology Center 
20 Community Drive 
Easton, PA 18042-2658 
(610) 258-6635 * Fax: (610) 258-2879 
Department of Medicine 
Division of Gastroenterology 
Site of Privileges - MHC 
Provisional Active 
Shashi L. Kumar, MD 
LVPG-Pediatric Surgery 
Allentown Medical Center 
401 N. 17th Street, Suite 302 
Allentown, PA 18104-5050 
(610) 402-7999 * Fax: (610) 402-7901 
Department of Surgery 
Division of Pediatric Surgery 
Site of Privileges - LVH & MHC 
Provisional Active 
Pamela F. LeDeaux, MD 
Lehigh Valley Family Health Center 
1730 Chew Street 
Allentown, PA 18104-5595 
(610) 402-3500 * Fax: (610) 402-3509 
Department of Family Practice 
Site of Privileges - LVH & MHC 
Provisional Active 
Timothy C. Lin, DMD 
Joseph A. Silvaggio, DMD, PC 
1991-B Catasauqua Road 
Allentown, PA 18103-1104 
(61 0) 866-8989 
Department of Dentistry 
Division of Endodontics 
Site of Privileges - LVH & MHC 
Provisional Active 
Daniel J. Miller, MD 
Neurosurgical Associates of L VPG 
1240 S. Cedar Crest Blvd., Suite 308 
Allentown, PA 18103-6264 
(610) 433-6166 * Fax: (610) 820-5357 
Department of Surgery 
Division of Neurological Surgery 
Site of Privileges- LVH & MHC 
Provisional Active 
Shanker Mukherjee, MD 
Twin Rivers Gastroenterology Center 
20 Community Drive 
Easton, PA 18042-2658 
(610) 258-6635 * Fax: (610) 258-2879 
Department of Medicine 
Division of Gastroenterology 
Site of Privileges - MHC 
Provisional Active 
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Charles J. Perruzzi, Jr., DMD 
88 W. Ridgewood Avenue 
Ridgewood, NJ 07 450 
(201) 652-8875 * Fax: (201) 848-0087 
Department of Dentistry 
Division of General Dentistry 
Site of Privileges - LVH & MHC 
Provisional Active 
Carla M. Rossi, MD 
3735 Nazareth Road, Suite 201 
Easton, PA 18042-8751 
(610) 923-9663 * Fax: (610) 923-9661 
Department of Medicine 
Division of Infectious Diseases 
Site of Privileges - MHC 
Provisional Active 
Christian F. Sorensen, MD 
Trexlertown Medical Center 
6900 Hamilton Blvd., P.O. Box 127 
Trexlertown, PA 18087-0127 
(610) 402-0101 * Fax: (610) 402-0102 
Department of Family Practice 
Site of Privileges - LVH & MHC 
Provisional Active 
G. Edward Streubert, MD 
Medical Imaging of LV, PC 
Muhlenberg Hospital Center 
2545 Schoenersville Road 
Bethlehem, PA 18017-7384 
(610) 861-2271 * Fax: (610) 867-7376 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Site of Privileges - LVH & MHC 
Provisional Active 
Deborah W. Sundlof, DO 
Lehigh Valley Cardiology Associates 
2597 Schoenersville Road, Suite 202 
Bethlehem, PA 18017-7396 
(610) 866-2233 * Fax: (610) 866-7738 
Department of Medicine 
Division of Cardiology 
Site of Privileges - LVH & MHC 
Provisional Active 
Joseph G. Trapasso, MD 
Urologic Associates of Allentown Inc. 
1240 S. Cedar Crest Blvd., Suite 310 
Allentown, PA 18103-6218 
(610) 437-9988 * Fax: (610) 437-4320 
Department of Surgery 
Division of Urology 
Site of Privileges - LVH & MHC 
Provisional Active 
Laura R. West, MD 
In practice with Paul K. Gross, MD 
Allentown Medical Center 
401 N. 17111 Street, Suite 304 
Allentown, PA 18104-5104 
(610) 820-3900 * Fax: (610) 820-3835 
Department of Psychiatry 
Site of Privileges - LVH & MHC 
Provisional Associate 
Address Changes 
Fernando M. Garzia, MD 
(No longer associated with Bethlehem Cardiothoracic Surgical 
Associates, PC) 
Opcor P.C. 
1941 Saucon Lane 
Bethlehem, PA 18015-5242 
(610) 866-6880 
Fax: (610) 866-6886 
The Heart Care Group, PC 
~ lan Chan, MD 
~ David B. Goldner, MD 
~ William M. Markson, MD 
~ Ronald A. Stein, MD 
451 Chew Street 
Suite 104 
Allentown, PA 18102-3423 
(610) 821-2841 
Fax: (610) 821-9700 
John D. Heid, DO 
Family Doctor, Inc. 
1040 Chestnut Street 
Emmaus, PA 18049-1998 
(610) 966-5549 
Fax: (610) 967-0204 
Michele D. Jones, DO 
(No longer associated with Riverside Medical Associates) 
The Pottsville Hospital and Warne Clinic 
420 S. Jackson Street 
Pottsville, PA 17901-3692 
(570) 621-5069 
Fax: (570) 621-5591 
Ravindra R. Kandula, MD, PC 
~ Ravindra R. Kandula, MD 
~ T. Kumar Pendurthi, MD, PhD 
2657 Schoenersville Road 
Bethlehem, PA 18017-7316 
Syed A. Subzposh, MD 
(No longer associated with The Heart Care Group) 
451 Chew Street 
Suite 302 
Allentown, PA 18102-3423 
(610) 821-2810 
Fax: (610) 821-6952 
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Appointment to Medical Staff Leadership Positions 
Oscar A. Morffi, MD 
Department of Pediatrics 
Position: Vice Chairperson, Department of Pediatrics 
Joseph G. Trapasso, MD 
Department of Surgery 
Position: Director of Urologic Oncology 
John & Dorothy Morgan Cancer Center 
Status Changes 
ln-Ho Chang, MD 
Department of Anesthesiology 
From: Active 
To: Honorary 
Lawrence P. Levitt, MD 
Department of Medicine 
Division of Neurology 
From: Active 
To: Affiliate 
Walter K. Peters, MD 
Department of Medicine 
Division of General Internal Medicine 
From: Limited Duty 
To: Honorary 
Eric J. Schenkel, MD 
Department of Medicine 
Division of Allergy 
From: Associate 
To: Affiliate 
Prakash N. Shah, MD 
Department of Medicine 
Division of General Internal Medicine 
From: Provisional Active 
To: Associate 
Amar J. Sharma, MD 
Department of Medicine 
Division of Allergy 
From: Active 
To: Associate 
Julie A. Stern, MD 
Department of Pediatrics 
Division of Hematology/Medical Oncology 
From: Provisional Associate 
To: Provisional Active 
Douglas C. Wiseman, DO 
Department of Medicine 
Division of Allergy 
From: Active 
To: Associate 
Leaves of Absence 
William W. Frailey, Jr., MD 
Department of Surgery 
Division of Surgery 
Two-Year Leave of Absence 
Daniel J. Kelley, MD 
Department of Surgery 
Division of Otolaryngology-Head & Neck Surgery 
Additional One-Year Leave of Absence 
David B. Sussman, MD 
Department of Surgery 
Division of Orthopedic Surgery 
Section of Ortho Trauma 
Six-Month Leave of Absence 
Anne E. VonNeida, MD 
Department of Medicine 
Division of General Internal Medicine 
One-Year Leave of Absence 
Resignations 
Hassan Bozorgnia, MD 
Department of Pediatrics 
Division of General Pediatrics 
Ahna S. Chu, MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Jay S. Cowen, MD 
Department of Medicine 
Division of Pulmonary 
Gregory Egan, MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Jacqueline A. Evans, DO 
Department of Obstetrics and Gynecology 
Division of Gynecology 
Mark B. Farin, MD 
Department of Pediatrics 
Division of Cardiology 
Lisa A. Fedullo, MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Hal L. Folander, MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Diane Garrigan, DO 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Page 11 
Medical Staff Progress Notes January, 2000 * Volume 12, Number 1 Page 12 
Gregory D. Harvey, MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Ellen A. Redstone, MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Michael I. Rothman, MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Vitaly Sawyna, MD 
Department of Surgery 
Division of General Surgery 
Gregg D. Schubach, MD 
Department of Radiology/Diagnostic Medical Imaging 
Division of Diagnostic Radiology 
Allied Health Professionals 
Appointments 
Stacy A. Benner, PA 
Physician Extender 
Physician Assistant - PA 
(Lehigh Neurology- Alexander D. Rae-Grant, MD) 
Site of Privileges - LVH & MHC 
Alyssa A. Dwyer, CRNP 
Physician Extender 
Professional - CRNP 
(CHOP-Pediatric Hematology/Oncology- Julie W. Stern, MD) 
Site of Privileges - LVH & MHC 
Kirandeep K. Gill, CRNP 
Physician Extender 
Professional - CRNP 
(CHOP-Pediatric Hematology/Oncology- Julie W. Stem, MD) 
Site of Privileges - LVH & MHC 
Patricia A. Landis, CST 
Physician Extender 
Technical- Surgical Technician 
(Orthopaedic Associates of Bethlehem, Inc. -Stephen P. Falatyn, MD) 
Site of Privileges - MHC 
Nancy M. Montgomery, RN 
Physician Extender 
Professional- RN 
(The Heart Care Group, PC -Joseph L. Neri, DO) 
Site of Privileges - LVH & MHC 
Daniele A. Shollenberger, CRNP 
Physician Extender 
Professional- CRNP 
(Neurosurgical Associates of LVPG - Mark C. Lester, MD) 
Site of Privileges- LVH & MHC 
William J. Waldron, CRNA 
Physician Extender 
Professional - CRNA 
(Allentown Anesthesia Associates Inc - Alphonse A. Maffeo, MD) 
Site of Privileges- LVH & MHC 
Resignations 
Amber J. Herring 
Physician Extender 
Technical- Dental Assistant 
(Marsha A. Gordon, DDS) 
Steven L. Muthler, CRNA 
Physician Extender 
Professional - CRNA 
(Allentown Anesthesia Associates Inc) 
THERAPEUTICS AT A GLANCE 
The following actions were taken at the November 1999 Therapeutics Committee Meeting- Clinical Pharmacy Services Joseph 
Ottinger, R.Ph., MS, MBA, Christopher Moore, R.Ph., James Sianis, Pharm.D., Eric Barber, Pharm.D. Candidate 
ADR Reporting 
AD R reporting for the second quarter 
continued to mirror previous periods as 
regards manifestations and the reporting 
parameters summarized in the tables below. 
Reporting incidence ratios defined as 
reports per 10,000 doses and reports per 
1,000 adjusted admissions continue to 
plateau after a period of decline, this 
despite increased reporting amongst nursing 
staff personnel. The availability of the 
unit-based pharmacists may have 
contributed in some manner to the overall 
decline in ADR rates over the past 2 years. 
In addition to the quarterly report, at least 
two case reports of bleeding following the 
administration of 'treatment doses' of 
lovenox = enoxaparin (lmg/kg q12h) were 
detailed (3rd quarter data). Both patients 
had estimated creatinine clearance values of 
< 30 ml/min. To date, this patient 
population has been excluded from all the 
published enoxaparin studies. It is assumed 
that this group of patients will accumulate 
drug to some degree, but a formalized 
recommendation as to what extent dosing 
should be altered has not been published. 
Monitoring aPTTs in LMWH therapy does 
not provide any insight as to the level of 
coagulation. The ideal method of 
assessment would be use of anti-factor Xa 
heparin levels (0. 3-0.7 units/ml = 
therapeutic), but they are currently not 
routinely available. The Therapeutics 
Committee recommended that a note be 
placed in the 'progress notes' section (will 
not be a permanent part of the chart) to 
alert physicians when this situation is 
identified to renal dose. A copy of this 
notification is included in this newsletter. 
Following are the particulars for this 
quarter: 
Second Quarter Data 
Table 1 : Adverse Reactions By Reporter 
Reporter # Reports % Reports 
Pharmacist 39 54.9 
Nurse 24 33.8 
X-Ray Technician 8 11.2 
Physician 0 0 
TOTAL 71 100 
Table 2: Adverse Reactions By Drug Category 
Drug Category # Reports % Reports 
Antibiotics 27 38 
Contrast Dyes 10 14.1 
Psych/Neurologic Agents 0 0 
Narc otic Analgesics 13 18.3 
Abciximab/heparin/TP A 8 11.3 
Dopamine 1 1. 4 
Cardiac 3 4.2 
Other 9 12.7 
TOTAL 62 100 
Table 3: Probability of Drug-Related Reactions 
Probability # Reports % Reports 
Doubtful 0 0 
Possible 23 32.4 
Probable 44 62 
Highly Probable 4 5.6 
TOTAL 71 100 
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Table 4: Adverse Reaction Severity 
Classification # Reports % Reports 
Mild 34 47.9 
Moderate 32 45 
Severe 5 7.1 
TOTAL 71 100 
Enoxaparin Notification 
Dear Doctor: Use of enoxaparin(Lovenox) 
in patients with compromised renal function 
in treatment regimens utilizing the lmg/ kg 
q12h dosing has not been studied. All 
published data to date have EXCLUDED 
this patient population, therefore no dosing 
guidelines are available to direct therapy in 
these individuals. There is data to suggest 
that the excretion of LMWHs will be 
reduced in moderate renal failure, leading 
to drug accumulation and a higher risk of 
bleeding. As LMWH's effects on 
anticoagulation cannot be monitored via 
"standard" laboratory measures, it would 
seem prudent to consider using another 
agent for anticoagulation. Therapeutic 
unfractionated heparin is generally 
considered equally effective and safe in all 
indications where treatment regimens of 
enoxaparin are currently approved. Thank 
you for your cooperation. 
Nasal Steroid Preparations 
To minimize therapy delays, unnecessary 
physician time spent handling formulary 
issues, and "inventory clutter", the 
Therapeutics Committee has approved an 
automatic substitution procedure for the 
currently available nasal steroid products. 
The guidelines and their rationale are 
outlined below: 
Automatic Substitution Guidelines for 
Corticosteroid Nasal Inhalation 
Formulations: 
All doses indicated for the products 
listed below will be automatically 
substituted with budesonide (Rhinocort or 
Rhinocort AQ) products at a dose of one-
two sprays into each nostril twice daily 
unless the patient is allergic to budesonide. 
The substitution will proceed based on the 
initial formulation ordered and the initial 
quantity of 'sprays'. Aqueous formulations 
will be changed to Rhinocort AQ and non-
aqueous products will be modified to 
Rhinocort. The number of 'sprays' per 
nostril will be continued into the new 
"substitution" order. No more than eight 
activations per day will be ordered. The 
pharmacist will write a clarifying order that 
will address this change in a timely fashion 
consistent with the relevant automatic 
substitution policies previously identified. 
Drug Name (Brand)/ Generic 




Beclomethasone AQ 42mcg 
Beclomethasone AQ-DS 84mcg 
Nasalide, Nasarel 
Flunisolide 25 meg 
Flonase 
Fluticasone 50 meg 
Nason ex 
Mometasone 50 meg 
Nasacort, Nasacort AQ 
1-2 spray(s) each 
nostril 4 times/day 
1-2 spray(s) each 
nostril 2x/day 
1-2 spray(s) each 
nostril/day 
1-2 sprays each 
nostril2x/day 
1-2 sprays each 
nostril/d or 1 
spray each nostril 
2x/day 
1-2 sprays each 
nostril/day 




No current product has been shown 
to be any more effective or safer in 
the patient population outlined 
(patients > 6 yo). 
Budesonide may have a lower risk 
of suppressing the HP A axis at 
higher doses. 
Cost issues appear to be translated 
for budesonide products across the 
inpatient to outpatient continuum. 
The ability to provide once daily 
dosing (thereby, improving the 
chances of compliance as an 
outpatient) is available with this 
product, but will not be 
incorporated into the automatic 
substitution guideline at this time. 
Herbal Remedies And 
Important Aspects of Herbal 
Therapy 
This educational effort was designed not to 
provide an all-encompassing review of 
herbal products, vitamins or alternative 
health products. There are numerous texts 
and other references that are now available 
to provide such information. This review 
will however provide a background about 
the recent explosion of alternative 
medications in today' s society. The goal of 
this article is to provide the reader with 
some examples of these products, potential 
interactions, and contraindications that 
should be observed. 
Even in today' s complex health care system 
25 % of prescription medications are still 
derived from plants.' Common examples 
of these drugs that are supported by 
controlled clinical trials and have gained 
widespread acceptance in the medical 
community are colchicine, morphine, 
pilocarpine, paclitaxel and many others.2 
After the ratification of the DSHEA in 
1994, the use of herbal remedies in the 
United States has skyrocketed. Today 
there are approximately 500 different herbs 
marketed in the U.S. today. In 1996, a 
survey done by International 
Communications Research demonstrated 
that the top ten herbs accounted for almost 
50% of herbal product sales. 3 
With the passage of the DSHEA the 
distinction between a medication and food 
is not always easy to make. A food is 
defined as articles or components used for 
food or drink. An example of this type of 
product is Benecol, which is a food, but 
has been "clinically proven to reduce 
LDL .... up to 14%". Since the definition of 
a drug is a therapeutic agent other than 
food used in the prevention, diagnosis, 
alleviation, treatment, or cure of disease,4 it 
is easy to become confused. 
Since the introduction of these products 
into the marketplace, information has been 
coming to light about possible drug/drug 
interactions with these products and 
prescription drugs. Several supplements 
have also been deemed to be unsafe by the 
FDA. Since there can be drug interactions 
with prescription medications that these 
patients are taking, both patients and their 
health care providers need to be aware of 
the potential for these interactions. The 
potential magnitude of this situation was 
realized after a recent study done here at 
Lehigh Valley Hospital. The following is a 
summary of the study findings. 
Hospitalized adult patients were eligible for 
enrollment in this study if they were 
admitted to LVH (Cedar Crest site) for any 
reason. Patients were chosen at random. 
Patients were excluded from this study if 
they were admitted from a nursing home, 
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unable to answer questions, have a history 
of dementia or under the age of 18. A 
pharmacist interviewed the majority of 
patients and a pharmacy student 
interviewed eight of the patients. The 
subjects were asked the following questions 
in the following order: 1. Do you take any 
vitamins or herbal supplements? 2. Do you 
know what I mean when I say herbal 
supplement? 3. Do you take any over the 
counter or any medications that you do not 
need a prescription for? 
Once this was accomplished, these results 
were compared against the results obtained 
by a registered nurse during the initial 
patient interview. The format is outlined in 
the Lehigh Valley Hospital Admission 
Record Part 1- Patient Questionnaire. This 
form asks the specific question: Are you 
taking any medications - List all prescribed 
and non-prescribed. (Form NSG-202-1) 
A total of 104 patients were evaluated. Of 
the 104 patients interviewed, 18 patients 
were taking herbal remedies. (17.3%). For 
the last fiscal year 1998-99, there were 
30,727 admissions to Lehigh Valley 
Hospital. If we apply the same percentage 
of patients in our small survey to the total 
number of admissions, an estimated 5,000 
patients yearly will be admitted to L VH 
that consume herbal remedies. As you can 
see, these products have significantly 
affected our community. To provide you 
with an idea of the potential interactions 
that can arise, a list of the top selling herbs 
in 1998 and their potential interactions has 
been provided. These are the agents that 
you are likely to see in clinical practice. 




4. Golden Seal 
5. Saw Palmetto 
6. Aloe 
7. Panax Ginseng 
8. Astralgus 
9. Cayenne 
10. Cat's Claw 
11. Siberian Ginseng 
12. Bilberry 
13. Cranberry 
14. Dong Quai 
15. Grape Seed 
16. Cascara 




Specific Product Interactions/ Contra-
indications with the top 20 herbal products 
Echinacea- avoid in progressive systemic 
diseases such as tuberculosis, collagenosis, 
multiple sclerosis. Avoid in patients with 
diabetes. 
Garlic- Can interact with aspirin, 
dipyridamole, and warfarin 
Gingko Biloba- Can interact with 
anticoagulants such as aspirin, warfarin, 
dipyridamole. 7 
Goldenseal- contraindicated in patients with 
high blood pressure 
Saw Palmetto- May affect existing 
hormonal therapy. 10 
Ginseng- Can lower blood sugar, can 
interact with diabetes medications. 
Dong Quai- Can have antiplatelet/ 
anticoagulant activity. Contraindicated in 
pregnancy. 
Grapeseed Extract- Used as an antioxidant 
' 
for diabetic retinopathy. Can interact with 
antiplatelet drugs and warfarin. 
Cat's Claw- Contraindicated in patients 
who are planning or have recently had skin 
grafts or organ transplants. Not 
recommended for hemophiliacs who are 
receiving 
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cryoprecipitate or FFP. Not recommended 
to be combined with passive vaccines 
composed of animal sera, intravenous 
thymic extracts, insulin (bovine or porcine) 
or other hormone therapies with animal 
proteo or peptide hormones. 11 Has been 
used as an abortifacient in traditional 
Peruvian medicine. 
Eleuthero (Siberian Ginseng)- Can 
exacerbate hypertension, avoid in patients 
with anxiety, mania, schizophrenia. 
St. John's Wort- Should not be used at the 
same time as prescription antidepressants. 
Ginger Rhizome- Due to in vitro anti-
platelet activity and in vivo hypoglycemic 
activity, it is believed by some that 
excessive doses of ginger can interfere with 
these therapies. 7 Caution is advised in 
patients with gallstones. 
As you can see, even with the limited 
information presented here, there are 
numerous potentials for interactions with 
prescription medications. Therefore at 
Lehigh Valley Hospital, we have 
recommended the following changes to the 
current procedures. When a patient is 
admitted, physicians may want to ask the 
specific question during the H + P, which 
states "do you take any vitamins or herbal 
medicines" . 
From a nursing standpoint, Nursing 
Practice Council has accepted 
recommendations that the Admission 
Record Part 1- Patient Questionnaire (form 
NSG-202-1) be altered. Final alterations 
have yet to be determined. Until that time 
it is recomrriended that the nursing staff 
continue to ask the question 11 are you taking 
any medications?". In addition, the 
question 11 do you take any vitamins or 
herbal medicines" should be asked as well. 
If the answer to the second question is yes, 
pharmacy should be notified. In that way, 
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the herbal remedy can be identified and 
added to the patients medication profile. 
The pharmacist shall screen for drug/ drug 
interactions. If any problems are found the 
pharmacist shall contact the physician via 
phone or by a note left in the chart. From 
this point, the medication may be used in 
the hospital according to patients own 
medication policy. (The patient's family 
should bring in their own supply). Please 
keep in mind that physicians are required to 
write an order for any product to be used 
by the patient's own medication policy. 
Please keep in mind however that this is for 
continuation of ongoing therapy only. 
Patients should not be STARTED on an 
herbal remedy at L VH. We are currently 
evaluating references to be made available 
to all members of the L VH network. It is 
our hope that once the decision is made, it 
will be available by the intranet or similar 
access. Until then, feel free to contact the 
clinical pharmacy office with questions 
about these products. There is also 
information available on the internet. 
Some of the more commonly used sites 
have been provided. 
Reliable resources for herbal information 
American Botanical Association 
www .herbalgram.org 
American Pharmaceutical Association 
www.aphanet.org 
American Society of Pharmacognosy 
www .temple.edu.ASP 
Food and Drug Administration 
www.fda.gov 
FDA Guide to Dietary Supplements 
www.fda.gov/fdac/features/1998/598 guid.html 
Herb Research Foundation 
www .herbs.org 
National Institutes of Health 
www .nal. usda.gov/fnic/IBIDS/ 




Pharmacist's Web Guide 
www .geocities.com/Heartland/Oaks/1591 
Urban Legends and Folklore 
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Resistance Rumors 
It is being reported, by unknown 
individuals, that Streptococcus pneumoniae 
is 30% resistant to levofloxacin at Lehigh 
Valley Hospital. The fact of the matter is 
that there are no resistance problems with 
levofloxacin and Streptococcus 
pneumoniae. The microbiology department 
has been doing susceptibility testing since 
this agent was added to formulary. There 
were 88 isolates tested from October 1998 
to November 1999 and 92% were 
susceptible. Macrolides on the other hand 
have not fared as well. Presently, there is 
25% resistance with Streptococcus 
pneumoniae. Currently, the hospital is 
only testing erythromycin, but the results 
can be used to interpret susceptibilities for 
other macrolides (Zithromax, Biaxin). 
Based on current L VH resistant patterns, 
macrolides would not be good empiric 
monotherapy choices if Streptococcus 
pneumoniae is the presumed organism. 
Ceftriaxone and levofloxacin are still 
excellent options for the treatment of 
community acquired pneumonia. If 
ceftriaxone is chosen, and atypical 
coverage is needed, then a macrolide is 
appropriate. Levofloxacin can be used 
monotherapy to cover the usual suspects in 
community -acquired pneumonia as well as 
the atypicals. When questions about 
resistance patterns in the hospital arise, 
please refer to the L VH Antibiogram or 
contact the Clinical Pharmacy Office, the 
Infectious Disease Division or the 
Microbiology Department. Antibiograms 
are located in the back of each patient 
chart. If you would like your own copy, 
please contact the Clinical Pharmacy Office 
(Ext. 8884) and we will provide you with 
one. Please use information concerning 
resistance patterns from pharmaceutical 
representatives with caution. They can 
often times be misinformed. If you have 
any questions, please contact me in the 
clinical pharmacy office. 
Two New 'Glitazones" Added 
The two recently approved "Rezulin" type 
agents were approved to the drug 
formulary. The status of troglitazone 
(Rezulin) has not changed. It will continue 
to be available until further data is obtained 
related to the safety of pioglitazone (Actos) 
and rosiglitazone (A vandia). A comparison 
chart for all the agents in this class is 
included in this newsletter. 
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Thiazolidinediones 
,-Generic Name Usual Dose Max Dose Mean FBG (mg/dl) & Contraindications Monitor Cost (AWP) Notes 
(Trade Name) HbA1C (%)decrease per 30 tablets 
Troglitazone 200 mg qd with food ( p 2-4 weeks ) (with glyburide) AL T 1.5 x upper limit, FBG and HbA1c, 200 mg $ 74.59 ..J,•s BCP's by 30%, 
(Rezulin) in combination t to 400 mg qd, 200 mg qd ( -31 /-0.7) NYHA Class 3 and 4, 300 mg $74.59 Add or t 
*Eli Lilly therapy. (p 2-4 weeks ) 400 mg qd ( -38/-0.9) Preg Category 8, Initial liver enzymes, 400 mg $ 118.80 contraception. 
t to 600 mg qd 600 mg qd ( -56/-1.8) Nursing Mothers, monthly x 1 year, 
200 mg tablets Initial monotherapy in combination therapy Type 1 OM or DKA then every 3 
300 mg tablets not recommended. with sulfonylureas, months. 
400 mg tablets metformin, or insulin. 
Rosiglitazone 4mgqd ( p 12 weeks) 2 mg bid ( -38/-0.3) AL T 2.5 x upper limit, FBG and HbA 1 c, 2 mg $43.61 Anovulatory may 
(Avandia) in 1-2 doses, tto 8 mg qd 4 mg qd ( -25/ 0.0 ) NYHA Class 3 and 4, 4mg $60.15 resume ovulation, 
*SKB monotherapy or in 1-2 doses, Preg Category C, Initial liver enzymes, 8 mg $ 109.78 Use adequate 
combination therapy. in monotherapy or 4 mg bid ( -54/-0.6 ) Nursing Mothers, then every 2 months contraception. 
2 mg tablets combination therapy 8 mg qd ( -42/-0.3 ) Type 1 OM or DKA x 12 months. 
4 mg tablets *with or without food with metformin or 
8 mg tablets insulin. 
Pioglitazone 15-30 mg qd 45 mg qd, 15 mg qd ( -30 I -0.3 ) AL T 2.5 x upper limit, FBG and HbA1c, 15 mg $71.43 h BCP's by 30%, 
(Actos) monotherapy or in monotherapy. 30 mg qd ( -32/ -0.3 ) NYHA Class 3 and 4, 30 mg $ 114.37 Add or t 
*Parke-Davis combination therapy. 30 mg qd in 45 mg qd ( -56/-0.9) Preg Category C, Initial liver enzymes, 45 mg $ 124.06 contraception. 
combination therapy Nursing Mothers, then every 2 months 
15 mg tablets *with or without food with sulfonylureas, Type 1 OM or DKA x 12 months. 
30 mg tablets metformin, or insulin. 
45 mg tablets 
Mechanism of Action: 
Thiazolidinediones act primarily by decreasing insulin resistance. They improve sensitivity to insulin in muscle and adipose tissue and inhibit hepatic gluconeogenesis. When used in 
combination therapy and hypoglycemia is reported, it is recommended that the dose of the second agent be reduced. 
Renal Dosage Adjustments: 
No dosage adjustments are required. 
Hepatic Dosage Adjustments: 
Thiazolidinediones should not be initiated in patients with clinical evidence of active liver disease or elevated serum transaminase (AL T). 
Lab Abnormalities: 
There may be an increase in total cholesterol, LDL, HDL, and FFA's , and a decrease in triglycerides, hematocrit (up to 4% difference) and hemoglobin {up to 1 gm/dl difference) with 
the use of thiazolidinediones. 
In treatment of premenopausal, anovulatory woman with insulin resistance, the addition of thiazolidinediones may result in resumption of ovulation. These patients may be at risk for 







THERAPEUTICS AT A GLANCE 
Th~ following actions were take~ at the December 1999 Therapeutics Committee Meeting- Clinical Pharmacy Services Joseph 
Ottmger, R.Ph., MS, MBA, Chnstopher Moore, R.Ph., James Sianis, Pharm.D. 
Loop Diuretic Autosubstitution 
The Therapeutics Committee approved the 
autosubstitution of furosemide for 
torsemide during the last committee 
meeting. This substitution includes both 
the intravenous and oral formulations. Both 
agents have an identical mechanism of 
action and there is no therapeutic advantage 
to using torsemide instead of furosemide. 
Orders written for torsemide will be 
substituted with furosemide on a two for 
one basis. If a patient is to be switched 
back to torsemide after discharge, 
remember to make the appropriate dosage 
adjustment. Please direct any questions or 
comments to the Clinical Pharmacy Office. 
IV to PO Step Down Additions 
Four medications were added to the IV to 
PO Step Down Program during the last 
meeting of the Therapeutics Committee. 
These agents are azithromycin IV, enalapril 
IV, metoprolol IV and metronidazole IV. 
Azithromycin (Zithromax®) will be 
converted to the oral formulation per the 
package insert. Azithromycin 500 mg IV 
will be converted to 250 mg PO q24h. If 
the patient is on 250 mg IV then that will 
be converted to 250 mg PO q24h. 
Metronidazole will be converted to the oral 
formulation on a mg per mg basis. The 
dosing interval will remain the same. 
Enalapril IV will be substituted with 
enalapril 5mg PO qd if the patient is not 
receiving a loop diuretic and titrated 
upward as necessary by the physician. If 
the patient is receiving a loop diuretic the 
IV will be converted to 2. 5 mg qd and 
titrated upward as necessary. Orders for 
enalapril written on an as needed basis will 
not be converted to PO. Metoprolol 2.5 
mg IV q6h will be converted to metoprolol 
12.5 mg PO q12h. Metoprolol 5 mg IV 
q6h will be converted to 25 mg PO q 12h. 
Orders written on an as needed basis will 
not be converted to PO. Please keep in 
mind that dosage titration may be required 
for the antihypertensive agents. Please 
direct any questions or comments to the 
Clinical Pharmacy Office. 
ADR Reporting 3rd Quarter 
ADR reporting for the third quarter 
continued to mirror previous periods as 
regards manifestations and the reporting 
parameters summarized below. Incidence 
ratios have increased by modest increments 
in each quarter's data, but remain 
significantly below 1998 levels. Reporting 
incidence ratios are defined as reports per 
10,000 doses and reports per 1, 000 
adjusted admissions. They were 0.8 and 
7.15, respectively. Last quarters rates 
were 0.74 and 6.73, respectively. 
Following are the particulars for this 
quarter: 
Third Quarter Data 
Table 1: Adverse Reactions By Reporter 
Reporter #Reports % Reports 
Pharmacist 53 72.6 
Nurse 12 16.4 
X-Ray Technician 6 8.2 
Physician ~ 2.8 
TOTAL 73 100 
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Table 2: Adverse Reactions By Drug Category 
Drug Category # Regorts % Regorts 
Antibiotics 33 45.2 
Contrast Dyes 7 9.6 
Psych/Neurologic Agents 4 5.5 
Narcotic Analgesics 4 5.5 
Abciximab/heparin!TP A 15 20.5 
Dopamine 0 0 
Cardiac 2 2.7 
Oncology 3 4.1 
Other ~ 6.8 
TOTAL 73 100 













Table 4: Adverse Reaction Severity 
















Enoxaparin Treatment doses 
Due to the product concentration of 
enoxaparin and the practical matter of 
preparing doses, the pharmacy will "round" 
all 1 mg/kg q 12h dosing regimens to the next 
lowest 5mg dose increment. For example, 
an 83 kg patient would receive an 80mg 
dose every 12 hours. 
Revised 'Stalin' Autosubstitution 
All cerivastatin (Baycol) dosing schemes 
will be automatically substituted with 
simvastatin at comparable doses. All agents 
in this class of drugs are now addressed by 








0.4mg PO QD 
·fluvastatin 
(Lescol) 
20mg PO QD 
40mg PO QD 












Autosubstitution Pharmacist duty 
simvastatin (Zocor) Order 12/99 
5mg PO QD 1800 clarification 
10mg PO QD 1800 will be 
20mg PO QD 1800 received 
from 
pharmacy 
simvastatin (Zocor)) Order 8/98 
5mg PO QD 1800 clarification 
lOmgPOQD 1800 will be 
20mg PO QD 1800 received 
from 
pharmacy 
simvastatin (Zocor) Order 8/98 
5mg PO QD l 800 clarification 
10mgPOQD 1800 will be 
20mgPOQD \800 received 
40mgPOQD 1800 from 
pharmacy 
simvastatin (Zocor) Order 8/98 
5mg PO QD 1800 clarification 
10mg PO QD 1800 will be 




All orders for atorvastatm (Ltpttor) wtll be dtspensed as wntten. 
Antibiotic Use at Lehigh Valley 
Hospital: Dispelling the Myths 
I am constantly in awe of the information, 
or sometimes misinformation that filters 
its way down to the Clinical Pharmacy 
Office about antibiotic usage here at 
Lehigh Valley Hospital. Some of the most 
common statements are "We use too much 
levofloxacin here" and "Levofloxacin is in 
the water". In actuality, levofloxacin IV 
isn't even in the top five antibiotics with 
regards to number of doses dispensed and 
number of patients who received the 
antibiotic. 
In fiscal year 1999, the Pharmacy 
Department dispensed a total of 295,574 
doses of antibiotics to 50,792 patients for 
a total cost of $1,315,417. The number 
one drug in terms of doses dispensed and 
patients treated was cefazolin IV. A total 
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of 17,695 patients received 55,554 doses of 
cefazolin for a total of $57,621. Below is a 
table highlighting the top seven antibiotics 
dispensed by the pharmacy by number of 
doses and number of patients who received 
the antibiotic. 
Drug #Doses Patient # 
Days' Cases 
Cefazolin IV 55,554 18,518* 17,695 
Gentamicin IV 19,893 6631* 2,777 
Ampicillin IV 18,091 4,523 2,725 
Clindamycin IV 17,165 5,722 1,641 
Vancomycin IV 16,646 8,323 3,107 
Metronidazole IV 15,406 5,135 1,757 
Cefazolin/Metronidazole IV 9,299 3,100 1,184 
Levotloxacin IV 8,265 8,265 2,609 ... I Thts number was calculated by dlvtdmg the number of doses by the number 
of times a day the antibiotic is usually administered. The figures for 
cefazolin may not reflect actual patient days because the drug is often 
times used for surgical prophylaxis. Due to extended interval dosing of 
aminoglycosides, the figure for gentamicin may not reflect the actual 
patient days 
It is true that the pharmacy dispenses a lot 
of levofloxacin and when the oral form of 
levofloxacin is taken into account this 
number increases dramatically. This is in 
large part due to the fact that levofloxacin is 
a valuable agent. It has a broad spectrum of 
activity, has a favorable pharmacokinetic/ 
pharmacodynamic profile and it is generally 
well tolerated. Levofloxacin has utility in a 
number of community acquired as well as 
hospital-acquired infections. Due to these 
properties, it is an attractive choice for 
empiric therapy when the offending 
organism is not known at the time the 
patient presents. 
Levofloxacin is used commonly to treat 
infections of the urinary tract, upper and 
lower respiratory tract and soft tissue and 
skin infections. This however, does not 
preclude the use of other antibiotics. When 
treating urinary tract infections often times a 
first generation cephalosporin such as 
cefazolin or cephalexin will do. With the 
exception of elderly patients, 
sulfamethoxazole/ trimethoprim is also 
another good option for the treatment of 
urinary tract infections. Cefazolin is an 
excellent choice for the treatment of most 
skin and soft tissue infections. For the 
treatment of upper and lower respiratory 
tract infections, ceftriaxone plus a 
macrolide has been a proven combination 
for a number of years. Doxycycline is an 
excellent agent for the treatment of upper 
and lower respiratory tract infections. 
Doxycycline covers the most common 
organisms as well as the atypicals. 
Due to their utility in a number of 
infections, fluoroquinolones will be part of 
the antibiotic armamentarium at most 
hospitals for many years to come. At the 
present time there are seven available 
fluoroquinolones on the market. Lehigh 
Valley Hospital currently has one on 
formulary. Levofloxacin was chosen 
because it had cost effective properties that 
made it a valuable addition to the Lehigh 
Valley Hospital Formulary. As this article 
points out, there are many antibiotics from 
which to choose here at Lehigh Valley 
Hospital. The decision to use or not use a 
particular antibiotic ultimately lies with the 
prescribing physician and what is 
currently available on formulary. 
Please keep in mind that it is the 
Pharmacy Department's intention to 
promote appropriate use of all 
medications. Before a medication is added 
to formulary the Pharmacy Clinical Office 
reviews all available clinical data and 
presents its findings to the Therapeutics 
Committee where a final decision is made. 
While one cannot ignore cost in the 
analysis, it is not what drives the final 
decision. First and foremost is the quality 
of care provided to Lehigh Valley Hospital 
patients. Please forward any comments or 
questions to Jim Sianis, Pharm.D. in the 
Clinical Pharmacy Office at 402-8894. 
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To schedule a one-on-one OVID (MEDLINE) 
training session, call Barbara Iobst in the Health 
Sciences Library at 610-402-8408. She can also 
instruct you in the use ofPubMed, a free, Web-
based MEDLINE service offered by the National 





"DECISION MAKING IN MEDICINE: AN 
ALGORITHMIC APPROACH," 2nd edition 
Author: H. Greene, II, et al. 




Guest Editor: A. Morgan 
Vol. 46, No. 5 
17 & Chew Library. 
***************** 
"CLINICAL OBSTETRICS AND 
GYNECOLOGY" 
Subjects: "CONTROVERSIES IN 
OBSTETRICS" I "CONTROVERSIES IN 
GYNECOLOGY" 
Guest Editors: R. Pitkin and J. Scott 
Vol. 42, No. 4 




Guest Editor: J. Wefel, et al. 
Vol. 43, No. 4 
MHC. 
****** 
"EMERGENCY CLINICS OF NORTH 
AMERICA" 
Subject: "ORTHOPEDIC EMERGENCIES" 
(Part 1) 
Guest Editor: D. Della-Giustina, et al. 
Vol. 17, No.4 
"MEDICAL CLINICS OF NORTH 
AMERICA" 
Subject: "SCREENING" 
Guest Editor: R. Lang, et al. 
Vol. 86, No.6. 
Library Hours 
CC & 1-78 Library - 8:30 a.m.-5:00p.m., 
Mon.-Fri. (telephone: 610-402-8410) 
17 & Chew Library - 9:30 a.m.-3:30p.m., 
Mon.-Fri. (telephone: 610-402-2263) 
MHC Library - 9:00 a.m.-1:00 p.m., 
Mon.-Fri. (telephone: 610-861-2237) 
Computer-Based Traininz: (CBT): 
Computer Based Training (CBT) programs are 
available for L VHHN staff. Topics covered by 
the CBT programs include: Access 2.0, 
PowerPoint 4.0, Windows NT 4, Word 97, Excel 
97, Access 97, PowerPoint 97, Lotus 1-2-3 
Millenium, WordPerfect 8, PHAMIS LastWord 
Inquiry Only commands, and E-mail GUI (check 
with your liS analyst to see if you have the GUI 
e-mail). 
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When liS upgrades your PCs from Windows 311 
to Windows NT, your office automation software 
will also be upgraded. Prepare for this upgrade 
by attending CBT sessions. Any questions about 
the NT upgrade should be directed to your liS 
analyst. 
CBT at LVH-CC takes place in Suite 401 ofthe 
Cancer Center (the computer training room). 
The schedule for L VH-CC is: 
1118/2000 12pm- 4pm 
1115/2000 l2pm - 4pm 
2/112000 8am - l2pm 
2/8/2000 12pm - 4pm 
2/22/2000 12pm- 4pm 
2/29/2000 8am - 12pm 
3/7/2000 12pm- 4pm 
3/2112000 12pm- 4pm 
3/28/2000 8am- 12pm 
CBT at MHC takes place in the computer 
training room (in the main hospital building just 
off the lobby). The schedule for MHC is: 
111112000 8am- 12pm 
2/15/2000 8am- 12pm 
3/14/2000 8am- 12pm 
At each site, twelve slots are available for each 
session. 
To register, please contact Bonnie Schoeneberger 
via e-mail or at 610-402-1210 telling her which 
session you want to attend. Include a second 
choice in case your first is already filled. You 
will receive an e-mail confirming your choice 
within two business days. 
We will be adding more CBT programs to our 
curriculum. We will announce any additions via 
e-mail. If you have any questions, please contact 
Craig Koller at 610-402-1427 or e-mail. 
ANNOUNCEMENTS 
The Pennsylvania Medical Society has approved 
full accreditation of Lehigh Valley Hospital and 
Health Network continuing medical education 
program, with joint sponsorship privileges, for a 
period of four year(s) ending October 2003. 
2 
Areas of Excellence Noted: 
(a) Needs assessment--a great job is being done 
at focusing and establishing true needs. 
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(b) Management Procedures--First class 
facilities, enviable administrative support 
and 
financing. 
CEDS is proud to announce that a $50,000 
grant has been received from the E. Rhodes and 
Leona B. Carpenter Foundation located in 
Philadelphia in support of the Network's clinical 
pastoral education (CPE) program. CPE brings 
theological students and ministers of all faiths 
into supervised encounters with people in crisis. 
ACCREDITATION COUNCIL FOR 
GRADUATE MEDICAL EDUCATION 
(ACGME) INSTITUTIONAL REVIEW 
Institutions sponsoring ACGME-accredited 
graduate medical education (GME) programs are 
required to undergo a periodic Institutional 
Review to monitor compliance with the 
ACGME's Institutional Requirements. Lehigh 
Valley Hospital's Institutional Review by the 
ACGME took place on November 17, 1999. 
Charles P. Joslyn, Ph.D., Field Representative 
for the ACGME, verified Lehigh Valley 
Hospital's documentation and implementation of 
policies and procedures identified in the 
ACGME's Institutional Requirements. Martyn 
0. Hotvedt, Ph.D., Director of Educational 
Development and Support, and Rosanne M. 
Rishko, Residency Program Coordinator, CEDS, 
prepared and presented the Institutional Review 
Document (IRD) and supporting documentation 
to Dr. Joslyn. The action of the Institutional 
Review Committee is based to a large extent 
upon the information submitted in the IRD. The 
results of the Institutional Review will be made 
known in April of2000. 
In addition to the Institutional Review Document, 
several interviews are required by the ACGME to 
verify the accuracy and completeness of the IRD. 
Robert J. Laskowski, MD, ChiefMedical· 
Officer, met individually with Dr. Joslyn. Next, 
Dr. Joslyn met with a group of nine program 
directors and physician educators from their 
respective residency programs. Included were 
Karen Bretz, MD, Jon Bmdjar, DO, John Cox, 
MD, Julie Dostal, MD, Gary Nicholas, MD, 
Walter Okunski, MD, Richard Snyder, MD, 
Stephen Klasko, MD, and Amil Qureshi, DO. 
Dr. Joslyn then met with twelve resident 
representatives who were chosen by the Lehigh 
Valley Residency Association from all of the 
residency programs. Attending were Scott 
Beman, MD, Jeffrey Brown, DO, Johnny Chung, 
MD, Jason Clem, MD, Jeffrey Faidley, MD, 
James Freeman, DO, Larry Fritchman, MD, Lou 
Lukas, MD, Todd Miller, MD, Miles Murphy, 
MD, Douglas Semian MD, and Jennifer Thome, 
MD. 
3 
The participation and involvement of the 
Graduate Medical Education Committee 
(GMEC), Administrators, program directors and 
physician educators, residents, and the support 
staff contributed to the success of the day. 
Any questions, concentl or comment1 011 article1 from CEDS, 
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